US EditionOutpatient Diuretic Intensification Could Be a Prognostic Marker for ATTR-CM
Summary by Rare Disease Advisor
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Outpatient Diuretic Intensification Could Be a Prognostic Marker for ATTR-CM
About 25% of patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) experience outpatient diuretic intensification within 6 months, a study found. The post Outpatient Diuretic Intensification Could Be a Prognostic Marker for ATTR-CM appeared first on Rare Disease Advisor
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage